5 Oct 2026, 15:11
Meetings & Governance—
RNVRENERVE LIMITED
Announcement history available from 1 August 2025
Fromto
5 Oct 2026, 13:20
PresentationsMS
21 Sept 2026, 09:08
Company UpdateMS
14 Sept 2026, 10:35
Substantial Holders—
14 Sept 2026, 10:19
Director Interests—
7 Sept 2026, 09:22
Company UpdateMS
3 Sept 2026, 09:49
Meetings & Governance—
28 Aug 2026, 09:42
Company Administration—
28 Aug 2026, 09:41
Company Administration—
28 Aug 2026, 09:40
Financial Results—
28 Aug 2026, 09:39
Financial Results—
28 Aug 2026, 09:35
Financial ResultsMS
25 Aug 2026, 12:59
Securities Administration—
25 Aug 2026, 12:54
Securities Administration—
25 Aug 2026, 09:09
Securities Administration—
19 Aug 2026, 10:38
PresentationsMS
12 Aug 2026, 10:16
Presentations—
10 Aug 2026, 10:44
Company UpdateMS
6 Aug 2026, 10:06
Company UpdateMS
3 Aug 2026, 11:17
Director Interests—
29 July 2026, 09:24
Quarterly ReportsMS
13 July 2026, 14:01
Securities Administration—
9 July 2026, 09:14
Securities Administration—
9 July 2026, 09:05
Capital RaisingMS
6 July 2026, 10:11
Company UpdateMS
16 June 2026, 09:02
Securities Administration—
16 June 2026, 09:01
Company Update—
11 June 2026, 09:47
Company UpdateMS
5 June 2026, 09:15
Company UpdateMS
1 June 2026, 09:44
Company UpdateMS
8 May 2026, 10:02
PresentationsMS
1 May 2026, 11:00
Presentations—
1 May 2026, 09:11
Securities Administration—
30 Apr 2026, 09:53
Director Interests—
30 Apr 2026, 09:50
Quarterly ReportsMS
15 Apr 2026, 09:45
Company UpdateMS
31 Mar 2026, 09:31
Securities Administration—
24 Mar 2026, 11:47
Securities Administration—
24 Mar 2026, 11:46
Securities Administration—
24 Mar 2026, 08:47
Securities Administration—
17 Mar 2026, 10:38
Presentations—
10 Mar 2026, 08:42
Presentations—
26 Feb 2026, 10:49
Financial ResultsMS
26 Feb 2026, 10:48
Financial ResultsMS
18 Feb 2026, 08:17
Securities Administration—
18 Feb 2026, 08:17
Securities Administration—
17 Feb 2026, 09:48
Securities Administration—
16 Feb 2026, 09:33
Periodic Reports—
30 Jan 2026, 10:27
Quarterly ReportsMS
15 Jan 2026, 09:17
Company UpdateMS
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 5 Oct 2026, 15:11 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 5 Oct 2026, 13:20 | ReNerve AGM Presentation | Presentations | MS | 03026, 15002 | |
| 21 Sept 2026, 09:08 | ReNerve completes first cases in Hong Kong and Malaysia | Company Update | MS | 11001 | |
| 14 Sept 2026, 10:35 | Change in substantial holding - J Chick | Substantial Holders | — | 02002 | |
| 14 Sept 2026, 10:19 | Change of Director's Interest Notice - J Chick | Director Interests | — | 02009 | |
| 7 Sept 2026, 09:22 | ReNerve and RMIT awarded $499k grant | Company Update | MS | 11001 | |
| 3 Sept 2026, 09:49 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 28 Aug 2026, 09:42 | ReNerve - Corporate Governance Statement | Company Administration | — | 03024 | |
| 28 Aug 2026, 09:41 | ReNerve - Appendix 4G | Company Administration | — | 03025 | |
| 28 Aug 2026, 09:40 | ReNerve - Full Year Results | Financial Results | — | 03003, 03014 | |
| 28 Aug 2026, 09:39 | ReNerve - 2026 Annual Report | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 28 Aug 2026, 09:35 | ReNerve - Appendix 4E | Financial Results | MS | 03003 | |
| 25 Aug 2026, 12:59 | Cleansing Notice | Securities Administration | — | 06018 | |
| 25 Aug 2026, 12:54 | Application for quotation of securities - RNV | Securities Administration | — | 06020 | |
| 25 Aug 2026, 09:09 | Proposed issue of securities - RNV | Securities Administration | — | 06013 | |
| 19 Aug 2026, 10:38 | Quarterly Investor Presentation | Presentations | MS | 03026 | |
| 12 Aug 2026, 10:16 | Quarterly Investor Webinar | Presentations | — | 12008, 14014 | |
| 10 Aug 2026, 10:44 | ReNerve Secures Marketing Approval in India | Company Update | MS | 11001 | |
| 6 Aug 2026, 10:06 | ReNerve Secures Marketing Approval in the Philippines | Company Update | MS | 11001 | |
| 3 Aug 2026, 11:17 | Change of Director's Interest Notice - J Chick | Director Interests | — | 02009 | |
| 29 July 2026, 09:24 | Q4 FY26 Activities Report and Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 13 July 2026, 14:01 | Notification regarding unquoted securities - RNV | Securities Administration | — | 06021 | |
| 9 July 2026, 09:14 | Proposed issue of securities - RNV | Securities Administration | — | 06013 | |
| 9 July 2026, 09:05 | ReNerve Secures up to A$5 Million Funding Facility | Capital Raising | MS | 03022, 06009 | |
| 6 July 2026, 10:11 | ReNerve Secures Marketing Approval in Indonesia | Company Update | MS | 11001 | |
| 16 June 2026, 09:02 | Notification of cessation of securities - RNV | Securities Administration | — | 06027 | |
| 16 June 2026, 09:01 | Clarification of Key Terms STC Distribution Agreement | Company Update | — | 11001 | |
| 11 June 2026, 09:47 | ReNerve appoints J4 as second Empliq manufacturing partner | Company Update | MS | 11001 | |
| 5 June 2026, 09:15 | ReNerve appoints distribution partner for Malaysian Market | Company Update | MS | 11001 | |
| 1 June 2026, 09:44 | New distribution agreement for broader Hong Kong market | Company Update | MS | 11001 | |
| 8 May 2026, 10:02 | Quarterly Investor Presentation | Presentations | MS | 03026 | |
| 1 May 2026, 11:00 | Quarterly Investor Webinar | Presentations | — | 14014 | |
| 1 May 2026, 09:11 | Notification of cessation of securities - RNV | Securities Administration | — | 06027 | |
| 30 Apr 2026, 09:53 | Final Director's Interest Notice - D Rhodes | Director Interests | — | 02010 | |
| 30 Apr 2026, 09:50 | Q3 FY26 Activities Report and Appendix 4C | Quarterly Reports | MS | 19003, 19008 | |
| 15 Apr 2026, 09:45 | Nerve Guide Matrix Enters Stage 3 of Commercial Development | Company Update | MS | 11001 | |
| 31 Mar 2026, 09:31 | Notification of cessation of securities - RNV | Securities Administration | — | 06027 | |
| 24 Mar 2026, 11:47 | Cleansing Notice | Securities Administration | — | 06018 | |
| 24 Mar 2026, 11:46 | Application for quotation of securities - RNV | Securities Administration | — | 06020 | |
| 24 Mar 2026, 08:47 | Proposed issue of securities - RNV | Securities Administration | — | 06013 | |
| 17 Mar 2026, 10:38 | Half Year Investor Presentation | Presentations | — | 03026 | |
| 10 Mar 2026, 08:42 | Half Year Investor Webinar | Presentations | — | 03027, 14014 | |
| 26 Feb 2026, 10:49 | 1HFY26 Results Announcement | Financial Results | MS | 03004, 03014 | |
| 26 Feb 2026, 10:48 | 1HFY26 Appendix 4D and Half Year Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 18 Feb 2026, 08:17 | Cleansing notice | Securities Administration | — | 06018 | |
| 18 Feb 2026, 08:17 | Application for quotation of securities - RNV | Securities Administration | — | 06020 | |
| 17 Feb 2026, 09:48 | Proposed issue of securities - RNV | Securities Administration | — | 06013 | |
| 16 Feb 2026, 09:33 | ReNerve Receives $517k R&D Refund | Periodic Reports | — | 03014 | |
| 30 Jan 2026, 10:27 | Q2 FY26 Activities Report and Appendix 4C | Quarterly Reports | MS | 19002, 19007 | |
| 15 Jan 2026, 09:17 | ReNerve receives approval in Malaysia | Company Update | MS | 11001 |
1–50 of 101
1 / 3